Vistagen Therapeutics Inc
For the period ended May 29, 2024. Filed Apr 16, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 29, 2024 · Filed Apr 16, 2024
Use the contents to explore the available documents and sections.
Contents
Cover page
Show cover page
DEF 14A 1 vtgn20240412_def14a.htm FORM DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the SEC Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material Pursuant to 14a-12 |
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required |
|---|---|
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
April 15, 2024
You are cordially invited to attend a virtual special meeting of stockholders (theMeeting or theSpecial Meeting) of Vistagen Therapeutics, Inc., a Nevada corporation (theCompany) to be held at 10:00 a.m., Pacific Daylight Time, on Wednesday, May 29, 2024. The accompanying proxy statement (theProxy Statement) details information regarding the Special Meeting, including a description of the proposals to be considered by stockholders at the Meeting and instructions for submitting your vote.
Your vote is very important to us. Whether or not you plan to attend the Special Meeting virtually, I encourage you to vote your shares by proxy as promptly as possible by following the instructions beginning on page 2 of the enclosed Proxy Statement. Our Board of Directors has unanimously approved the proposals set forth in the Proxy Statement, and we recommend that you vote in favor of each such proposal.
Thank you for your continued support of the Company. We look forward to your participation at the Special Meeting.
Sincerely, /s/ Margaret FitzPatrick Margaret FitzPatrick Board Chair
-i-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.